Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06745999 · ClinicalTrials.gov registry record · Phase 4
Cryotherapy in Combination with Red Light PDT for Actinic Keratosis of Full Face
A Phase 4 study of Actinic Keratoses, sponsored by Psoriasis Treatment Center of Central New Jersey.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06745999: Recruiting Phase 4 study of Actinic Keratoses, sponsored by Psoriasis Treatment Center of Central New Jersey.
NCT06745999 is a Phase 4 study of Actinic Keratoses that is actively recruiting participants, run by Psoriasis Treatment Center of Central New Jersey. The registered enrollment target is 40 participants, below the 95-participant average among 12 other Actinic Keratoses trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06745999, a Phase 4 study of Actinic Keratoses, is actively recruiting participants, sponsored by Psoriasis Treatment Center of Central New Jersey.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
40 patients randomized 1:1 to receive cryotherapy followed by 10% ALA gel Red light PDT vs. to 10% ALA gel Red Light PDT followed by cryotherapy.
Conditions Studied
Interventions
- DRUG Ameluz 10% Topical Gel
- DEVICE Red Light PDT
- PROCEDURE Cryotherapy
Study Locations (1)
New Jersey
- Psoriasis Treatment Center of New Jersey - East Windsor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-05-03 |
| Est. Completion | 2025-06 |
| Phase | Phase 4 |
What NCT06745999 shows while recruiting
NCT06745999 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 95-participant average among 12 other Actinic Keratoses trials with a reported enrollment target (58% lower).
The record links to 1 condition, with Actinic Keratoses appearing as the primary indexed condition, and to 3 interventions - of which Ameluz 10% Topical Gel is the first listed.
NCT06745999 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT06745999 about?
NCT06745999 is a clinical study titled "Cryotherapy in Combination with Red Light PDT for Actinic Keratosis of Full Face". 40 patients randomized 1:1 to receive cryotherapy followed by 10% ALA gel Red light PDT vs. to 10% ALA gel Red Light PDT followed by cryotherapy.
What is the current status of trial NCT06745999?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2023-05-03. Estimated completion is 2025-06.
What conditions does trial NCT06745999 study?
This clinical trial studies the following conditions: Actinic Keratoses.
What interventions are being tested in trial NCT06745999?
The interventions under investigation include: Ameluz 10% Topical Gel (DRUG), Red Light PDT (DEVICE), Cryotherapy (PROCEDURE).
Who is sponsoring clinical trial NCT06745999?
This trial is sponsored by Psoriasis Treatment Center of Central New Jersey, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06745999 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Actinic Keratoses
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06745999's enrollment target sits among peer trials
40 8th of 12 higher than 5 of 12 other Actinic Keratoses trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Actinic Keratoses trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating Skin Appearance Following 5-Flourouracil Cream for Treatment of Actinic Keratosis and the Effects of Topical Agents
COMPLETED · Phase 4
-
Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia
RECRUITING · NA
-
The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population
RECRUITING · NA
-
Photodynamic Therapy Incubation Times for Actinic Keratosis
ACTIVE NOT RECRUITING · NA
-
Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp
ACTIVE NOT RECRUITING · Phase 3
-
Continuous Quality Improvement (CQI) Pilot Study Evaluating the Utility of an Educational Video
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI